The results revealed that in pancreatic cancer patients (n = 89), high GSTK1 expression was significantly associated with shorter overall survival (OS) (HR = 1.6, p = 0.027, p(HR) = 0.029) (Figure 6E). Here, GSTK1 is linked to pancreatic neoplasm.